Autopsy report · NCT00574860
EN3285 for the Prevention or Delay of Oral Mucositis in Patients With Head and Neck Cancer
Cause of deathOther
“Additional research”
Life of this trial
- Ran for about 1 year 6 months before it stopped.
- 240 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Sponsor type
- Industry
- Conditions
- Oral Mucositis; Head and Neck Cancer
- Interventions
- EN3285; Placebo; Standard of care
- Participants
- 240
- Sites
- 2
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.